Shattuck Labs (STTK) Stock Analysis & AI Equity Report

Biotechnology USD Explore free reports

Shattuck Labs (STTK) overview

Shattuck Labs (STTK) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 1.0m and operating profit of USD -51.5m; the year-end share price was 3.65 USD and market capitalisation was USD 231m. Shattuck Labs is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Shattuck Labs's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 82.4mFY 2025
Share price3.65 USDFY 2025 year end
RevenueUSD 1.0mFY 2025
Operating profitUSD -51.5mFY 2025
Net earningsUSD -48.8mFY 2025
Market capitalisationUSD 231mFY 2025 year end

About Shattuck Labs

Shattuck Labs is a clinical-stage biotechnology company developing monoclonal and bispecific antibodies that block the DR3 receptor for inflammatory and immune-mediated diseases. Its lead candidate, SL-325, is a DR3-blocking monoclonal antibody being evaluated in a Phase 1 clinical trial. The company’s research and development work focuses on therapies targeting the DR3/TL1A pathway, including potential treatments for inflammatory bowel disease.

Generate the Shattuck Labs report

Shattuck Labs is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Shattuck Labs and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Shattuck Labs

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.